Shandong Baofa Cancer Institute

Shandong Baofa Cancer Institute is a specialized oncology research and clinical organization founded by Dr. Yu Baofa. The institute is renowned for its proprietary Ultra-minimum Incision Personalized Intratumoral Chemotherapy (UMIPIC) technology, a therapeutic approach that delivers high-concentration chemotherapeutic agents directly into solid tumors. By combining cytotoxic drugs with a slow-release oxidant, the UMIPIC method aims to induce systemic immune responses while reducing the side effects typically associated with systemic chemotherapy. The institute operates a network of specialized cancer hospitals in China, including facilities in Jinan, Beijing, and Tai'an. Its research focuses on treating advanced solid tumors that are often resistant to conventional therapies, such as pancreatic and lung cancers.